Clinical Trials in Xuhui District, China
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
IMmune Proteomics to Predict NeoAdjuvant Chemotherapy and ImmunoTherapy Response in Gastric Cancer
Gastric Cancer, Gastroesophageal Junction Cancer
Shanghai Zhongshan Hospital206 enrolled1 locationNCT06662110